Colorectal carcinomas - Role of p53

2019 ◽  
Vol 11 (3) ◽  
pp. 144-149
Author(s):  
Sindu V ◽  
◽  
Priyadharshini M ◽  
PLoS ONE ◽  
2018 ◽  
Vol 13 (11) ◽  
pp. e0207227 ◽  
Author(s):  
Evangelos Koustas ◽  
Athanasios G. Papavassiliou ◽  
Michalis V. Karamouzis

BMJ ◽  
1974 ◽  
Vol 4 (5941) ◽  
pp. 382-385 ◽  
Author(s):  
A. M. Mackay ◽  
S. Patel ◽  
S. Carter ◽  
U. Stevens ◽  
D. J. R. Laurence ◽  
...  

2002 ◽  
Vol 45 (5) ◽  
pp. 674-680 ◽  
Author(s):  
Mark W. A. Norrie ◽  
Nicholas J. Hawkins ◽  
Alison V. Todd ◽  
Alan P. Meagher ◽  
Terence W. OʼConnor ◽  
...  

2018 ◽  
Vol 10 (11) ◽  
pp. 367-369 ◽  
Author(s):  
Evangelos Koustas ◽  
Panagiotis Sarantis ◽  
Athanassios G Papavassiliou ◽  
Michalis V Karamouzis

2004 ◽  
Vol 180 (4) ◽  
pp. 201-208 ◽  
Author(s):  
Athanassios C. Tsamandas ◽  
Dimitrios Kardamakis ◽  
Panagiota Ravazoula ◽  
Vassiliki Zolota ◽  
Stavroula Salakou ◽  
...  

Cancers ◽  
2019 ◽  
Vol 11 (6) ◽  
pp. 776 ◽  
Author(s):  
Christina Susanne Mullins ◽  
Michael Gock ◽  
Mathias Krohn ◽  
Michael Linnebacher

Despite the importance of tumor infiltrating B cells (TiBc) in immunological circuits, their functional role is scarcely investigated. Here, we analyzed immunoglobulin (Ig) secretion of the subtypes IgA, IgG, and IgM of TiBc from freshly resected primary and secondary colorectal carcinomas (CRC) by FluoroSpot (n = 30 CRC) directly ex vivo. High, intermediate, and low secretion was observed in 33%, 37%, and 30% of the tumors for IgA; in 10%, 27%, and 63% for IgG; and in 21%, 36%, and 50% for IgM, respectively. These ex vivo data validate our previous findings: Most TiBc present in the CRC microenvironment are functional since they produce and actively secrete Ig (IgA > IgG > IgM). Of note, the presence of major histocompatibility complex (MHC) class II expressing cells in the tumor micromilieu only correlated with IgG secretion (p = 0.0004). Supporting recent findings in several other tumor entities, TiBc in CRC thus likely can contribute to tumor control in a dual role of sole antigen-presentation and additionally anti-tumoral Ig-production.


2020 ◽  
Vol 21 (20) ◽  
pp. 7526
Author(s):  
Giacomo Lettini ◽  
Valentina Condelli ◽  
Michele Pietrafesa ◽  
Fabiana Crispo ◽  
Pietro Zoppoli ◽  
...  

Wnt/β-Catenin signaling is involved in embryonic development, regeneration, and cellular differentiation and is responsible for cancer stemness maintenance. The HSP90 molecular chaperone TRAP1 is upregulated in 60–70% of human colorectal carcinomas (CRCs) and favors stem cells maintenance, modulating the Wnt/β-Catenin pathway and preventing β-Catenin phosphorylation/degradation. The role of TRAP1 in the regulation of Wnt/β-Catenin signaling was further investigated in human CRC cell lines, patient-derived spheroids, and CRC specimens. TRAP1 relevance in the activation of Wnt/β-Catenin signaling was highlighted by a TCF/LEF Cignal Reporter Assay in Wnt-off HEK293T and CRC HCT116 cell lines. Of note, this regulation occurs through the modulation of Wnt ligand receptors LRP5 and LRP6 that are both downregulated in TRAP1-silenced cell lines. However, while LRP5 mRNA is significantly downregulated upon TRAP1 silencing, LRP6 mRNA is unchanged, suggesting independent mechanisms of regulation by TRAP1. Indeed, LRP5 is regulated upon promoter methylation in CRC cell lines and human CRCs, whereas LRP6 is controlled at post-translational level by protein ubiquitination/degradation. Consistently, human CRCs with high TRAP1 expression are characterized by the co-upregulation of active β-Catenin, LRP5 and LRP6. Altogether, these data suggest that Wnt/β-Catenin signaling is modulated at multiple levels by TRAP1.


2009 ◽  
Vol 7 (2) ◽  
pp. 353
Author(s):  
M. Baek ◽  
T. Ahn ◽  
D. Jeong ◽  
S. Cho ◽  
J. Kim ◽  
...  

PLoS ONE ◽  
2020 ◽  
Vol 15 (6) ◽  
pp. e0235065
Author(s):  
Larisse Silva Dalla Libera ◽  
Thalita de Siqueira ◽  
Igor Lopes Santos ◽  
Jéssica Enocencio Porto Ramos ◽  
Amanda Xavier Milhomen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document